Infectious risk during mogamulizumab therapy in mycosis fungoides and Sézary syndrome.
Alejo Fernandez-Baillo JL, Hinojosa Garcés FC, Hernández Madrid P, Porres Lopez E, Gotor Rivera A, Calvo Asín CJ, Ortiz Romero PL, Arroyo Andrés J, Calleja Algarra A
Journal der Deutschen Dermatologischen GesellschaftIn the feed 19 Aug 2026, published online 19 Aug 2026, issue 2026 Aug 19, added to PubMed 19 Aug 2026
Topics: Skin cancer & tumorsCutaneous lymphomaInfections & infestationsCancer drugs
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42615429 · DOI 10.1111/ddg.70555